SMS Pharmaceuticals Limited Stock: price and insider trades · India

This page follows insider dealings at SMS Pharmaceuticals Limited as filed with SEBI (PIT + SAST), a company from the Health Care sector. From 24 October 2025 to 24 October 2026, the disclosure feed for SMS Pharmaceuticals Limited logged 12 filings by 7 insiders.

Open-market activity splits into 1 purchase totalling €9,550 and 10 sales totalling €89k; 1 insider sit on the buying side and 5 insiders on the selling side. The net balance comes to €80k on the selling side. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. G. Suresh Kumar filed the largest sale, €18k, on 28 February 2026.

The last insider purchase was made public on 24 August 2026, 61 days ago. Between a trade and the moment it shows up on SEBI (PIT + SAST), the median delay is 1 day. This delay matters because a trade only becomes useful information once it is public. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives.

For context, the typical company on the same exchange (median of 1,892 companies) published 4 filings over the same period, against 12 filings here. The full history, which starts in 2023, counts 2 purchases against 10 sales.

Other companies in the same sector with recent insider buying flagged by our signals: Dynavox Group AB and EssilorLuxottica. Every figure here comes from the filings published by SEBI (PIT + SAST) and describes the past, not future prices; it is not investment advice.